Skip to content

Inflammatory Cytokines and Oxidative Stress Biomarkers in Diabetic Chronic Kidney Disease Patients

Inflammatory Cytokines and Oxidative Stress Biomarkers Response to Life Style Modification in Diabetic Chronic Kidney Disease Patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07657286
Acronym
intervention
Enrollment
60
Registered
2026-06-18
Start date
2026-06-07
Completion date
2026-09-07
Last updated
2026-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease, Diabetes

Keywords

Diabetes; Weight Reduction; Oxidative Stress; Cytokines; Obesity.

Brief summary

This research intends to analyze how a 12-week adjustment in lifestyle influences inflammatory cytokines and oxidative stress indicators in overweight individuals diagnosed with type 2 diabetes and moderate CKD

Detailed description

: 60 patients, mostly sedentary, aged 36-58 years, were diagnosed with stages 3 and 4 chronic kidney disease (eGFR 25 to 60 ml/min/1.73 m²) with concomitant type 2 diabetes and indicated body mass indexes (BMI) between 30 to 35 kg/m². The subjects were randomly assigned to two unique groups: Intervention group (Group A): Participants completed supervised aerobic treadmill exercises while sticking to a calorie-limited diet (1200 kcal/day) throughout a 12-week period. Control group (Group B): Participants received standard nephrology care without any alterations in lifestyle. In the initial phases, there was a detailed analysis of biomarkers which was later confirmed in a review conducted at the 12-week mark focusing on TNF-α, IL-6, sCRP, CD, MDA, GSH, GPx, and SOD.

Interventions

OTHERaerobic treadmill exercises

diet (1200 kcal/day)

Sponsors

Badr University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
36 Years to 58 Years
Healthy volunteers
No

Inclusion criteria

* sedentary lifestyle for at least three months prior to enrollment * body mass index (BMI) of 30-35 kg/m².

Exclusion criteria

* using tobacco * heart failure * coronary arteries * severe heart valve problems * pregnant * liver inflammation * kidney transplant * physical injuries restricting them from exercising * utilization of anti-inflammatory medications

Design outcomes

Primary

MeasureTime frameDescription
MDAat baseline and after 12 WEEKSmalondialdehyde
GSHat baseline and after 12 WEEKSGlutathione
GPxat baseline and after 12 WEEKSGlutathione peroxidase
SODat baseline and after 12 WEEKSSuperoxide dismutase
IL-6at baseline and after 12 WEEKSInterleukin-6
TNF-αat baseline and after 12 WEEKStumor necrosis factor alpha
CRPat baseline and after 12 WEEKSC-reactive protein

Secondary

MeasureTime frameDescription
BMIat baseline and after 12 WEEKSBody mass index

Countries

Egypt

Contacts

CONTACTMona Mohamed Abdelkhalek, assistance professor
3m.sons@gmail.com00201024056108
PRINCIPAL_INVESTIGATORMona Mohamed Abdelkhalek

Badr University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 19, 2026